Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard‐risk cytogenetics

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|170|4|523-531

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.170, Iss.4, 2015-08, pp. : 523-531

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predictors of early response to initial therapy in patients with newly diagnosed symptomatic multiple myeloma

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 361-8609, Iss. 10, 2015-10 ,pp. : 888-891

John Wiley & Sons Inc

Access to resources Recommend Favorite

Enumeration and characterization of circulating multiple myeloma cells in patients with plasma cell disorders

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 1, 2018-01 ,pp. : 71-81

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Report of 134 Newly Diagnosed Multiple Myeloma Patients with Renal Impairment

By  

Acta Haematologica, Vol. 135, Iss. 3, 2015-11 ,pp. : 140-145

Karger

Access to resources Recommend Favorite

Microvessel Density as a Surrogate Prognostic Marker in Patients with Multiple Myeloma: A Meta-Analysis

By  

Acta Haematologica, Vol. 138, Iss. 2, 2017-08 ,pp. : 77-84

Karger

Access to resources Recommend Favorite

Serum Growth Differentiation Factor 15 Levels in Newly Diagnosed Multiple Myeloma Patients

By  

Acta Haematologica, Vol. 131, Iss. 3, 2013-11 ,pp. : 173-178

Karger

Access to resources Recommend Favorite